The financial markets were delivered a one-two punch March 9 – a plunge in oil prices along with fears that the coronavirus is continuing to spread unabated. As a result, the Dow Jones Industrial Average cratered 1,500 points in early trading after a brief halt with market circuit breakers kicking in. Biopharma equities did not escape the carnage, with the BioWorld Biopharmaceutical index trading down about 4% by market close, with the Dow closing down 7.8%.
HONG KONG – U.S., China and the Netherlands-based Harbour Biomed Therapeutics Ltd. has teamed up with Mount Sinai Health System, New York City's largest academic medical system, to develop novel biotherapies in oncology and immunology. The two parties will also be using Harbour’s H2L2 Harbour Mice platform to develop a monoclonal antibody (MAb) against the coronavirus that has turned into a global epidemic.
LONDON – The World Health Organization (WHO) has released its COVID-19 R&D roadmap, highlighting the gaps in knowledge about the virus and setting out priorities for research. The organization is now calling on groups around the world to use the document – drawn up by 400 experts – to coordinate their efforts.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, BMS, Compugen, Cytodyn, Dare, Faron, FSD, Gemoab, Kala, Retrophin, Revolution, Terns, Viiv.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alertwatch, American College of Cardiology, Avellino Labs USA, Clinical Computer Systems, Cybermdx, Exagen, Eyedaptic, Hologic, Htc Vive, Invacare, Invicro, LHC Group, Medicortex Finland, Northwell Labs, Nyxoah, Pavmed, Penumbra, Relyens, Sanmina, Sham, Soliton, Ulab Systems, Vispero.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aguair, Anthem, Avricore, Blue Cross, Ehealth Technologies, Enzo Biochem, Labcorp, Mologic, Silk Road Medical.
RSS
